Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study

NCT06487026 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-07-05

No results posted yet for this study

Summary

An Extension Study to Evaluate the Safety of ArcBlate MRgHIFU in Patients with Painful Bone Metastases

Conditions

Interventions

DEVICE

ArcBlate Focused Ultrasound Ablation System

MR-guided High Intensity Focused Ultrasound (MRgHIFU)

Sponsors & Collaborators

  • EpiSonica

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-07-31
Completion
2025-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06487026 on ClinicalTrials.gov